SG80553A1 - Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract - Google Patents

Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract

Info

Publication number
SG80553A1
SG80553A1 SG9610256A SG1996010256A SG80553A1 SG 80553 A1 SG80553 A1 SG 80553A1 SG 9610256 A SG9610256 A SG 9610256A SG 1996010256 A SG1996010256 A SG 1996010256A SG 80553 A1 SG80553 A1 SG 80553A1
Authority
SG
Singapore
Prior art keywords
pharmaceutical preparation
digestive tract
low
polymer film
releasable
Prior art date
Application number
SG9610256A
Other languages
English (en)
Inventor
Hatano Harumi
Ito Takahiro
Ishibashi Takahiro
Yoshino Hiroyuki
Mizobe Masakazu
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SG80553A1 publication Critical patent/SG80553A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG9610256A 1995-07-20 1996-07-13 Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract SG80553A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18365595 1995-07-20

Publications (1)

Publication Number Publication Date
SG80553A1 true SG80553A1 (en) 2001-05-22

Family

ID=16139614

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9610256A SG80553A1 (en) 1995-07-20 1996-07-13 Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract

Country Status (13)

Country Link
US (1) US6309666B1 (de)
EP (1) EP0754452B1 (de)
KR (1) KR100389602B1 (de)
CN (1) CN1076964C (de)
AT (1) ATE225165T1 (de)
CA (1) CA2181502C (de)
DE (1) DE69624047T2 (de)
DK (1) DK0754452T3 (de)
ES (1) ES2184846T3 (de)
ID (1) ID17428A (de)
PT (1) PT754452E (de)
SG (1) SG80553A1 (de)
TW (1) TW514533B (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
AU750451B2 (en) * 1997-02-13 2002-07-18 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
CN1296417A (zh) 1998-02-10 2001-05-23 卫福有限公司 控释制剂
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA69413C2 (uk) 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
WO2000018396A1 (fr) * 1998-09-25 2000-04-06 Sankyo Company, Limited PREPARATIONS A BASE D'INHIBITEUR DE HMG-CoA
CN100358509C (zh) * 1998-09-28 2008-01-02 沃纳-兰伯特公司 采用hpmc胶囊进行肠和结肠传递
JP2000247911A (ja) 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
EP1197228A4 (de) 1999-07-02 2004-03-10 Hisamitsu Pharmaceutical Co Arzneimittel für die behandlung von kolorektalem krebs
AU3400501A (en) * 2000-02-28 2001-09-12 Vectura Ltd Improvements in or relating to the delivery of oral drugs
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
JP4875277B2 (ja) 2000-06-16 2012-02-15 田辺三菱製薬株式会社 放出ｐＨ域及び／又は速度制御組成物
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7316819B2 (en) * 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
JP4031232B2 (ja) * 2001-11-09 2008-01-09 カプスゲル・ジャパン株式会社 新規カプセル
US7101565B2 (en) 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US6982253B2 (en) * 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US7320583B2 (en) * 2003-04-16 2008-01-22 Frito-Lay North America, Inc Apparatus and method for producing colored extruded food products
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
GB0320522D0 (en) 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
TW201240679A (en) 2004-03-12 2012-10-16 Capsugel Belgium Nv Pharmaceutical formulations
US20050283097A1 (en) * 2004-06-18 2005-12-22 Ultrastop Ltd. Devices and methodologies useful in non invasive termination of pregnancy
DE102004046102B4 (de) * 2004-09-23 2009-09-03 Mars Inc. Indikatorgranulat
GB0427456D0 (en) * 2004-12-15 2005-01-19 Phoqus Pharmaceuticals Ltd Formulation for production of capsule shells and capsules
BRPI0611492B1 (pt) * 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
WO2006130187A1 (en) * 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
US20070014847A1 (en) * 2005-07-05 2007-01-18 Ahmed Salah U Coated capsules and methods of making and using the same
US20070196399A1 (en) * 2006-02-21 2007-08-23 Shin-Etsu Chemical Co., Ltd. Enteric-coated preparation covered with enteric coating material for site-specific delivery of drug to site within the small intestine
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
CN101910113A (zh) 2007-12-28 2010-12-08 怡百克制药公司 左旋多巴控释制剂及其用途
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010080730A2 (en) * 2009-01-09 2010-07-15 Mayo Foundation For Medical Education And Research Methods and materials for delivering bile acids
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2012024767A1 (en) * 2010-08-25 2012-03-01 Grant Rufus Sparling Ii Improved enteric active substance delivery
AU2012305915B2 (en) 2011-09-07 2017-09-07 Roland Saur-Brosch Formulation for the controlled release of one or several substances in the digestive tract of a mammal
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
DE102011082716A1 (de) * 2011-09-14 2013-03-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Indikatorelement mit einer von einer in kontakt zu bringenden substanz abhängigen farbgebung
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
WO2015054302A1 (en) 2013-10-07 2015-04-16 Impax Laboratories, Inc. Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
CN108884171B (zh) 2016-04-08 2022-02-18 株式会社大赛璐 纤维素酯及其成型体
EP3485879A1 (de) * 2017-11-17 2019-05-22 Maat Pharma Orale pharmazeutische formulierung enthaltend bakterien
US20210113479A1 (en) * 2018-05-03 2021-04-22 M.W. Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract
EP3862022B1 (de) * 2018-10-02 2024-06-12 Qualicaps Co., Ltd. Hartkapsel mit verbesserter festigkeit und herstellungsverfahren dafür
KR102106244B1 (ko) * 2019-10-30 2020-05-04 한국광기술원 앵커를 구비하는 캡슐형 광역학 치료장치
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen
CA3216359A1 (en) 2021-04-07 2022-10-13 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
WO2023174722A1 (en) * 2022-03-15 2023-09-21 Evonik Operations Gmbh Pre-functionalized hard shell capsule with accelerated drug release at ph value 5 to 5.5

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0338383A2 (de) * 1988-04-16 1989-10-25 Schwarz Pharma Ag Oral zu verabreichende pharmazeutische Zubereitung mit kontrollierter Wirkstofffreisetzung und Verfahren zu deren Herstellung
EP0386801A2 (de) * 1985-09-26 1990-09-12 Chugai Seiyaku Kabushiki Kaisha Arzneimittel mit langsamer Wirkstofffreisetzung
EP0425699A1 (de) * 1989-05-11 1991-05-08 Chugai Seiyaku Kabushiki Kaisha Mundzubereitung zur verabreichung an bestimmter stelle des darmes
US5395628A (en) * 1989-12-28 1995-03-07 Tanabe Seiyaku Co., Ltd. Controlled release succinic acid microcapsules coated with aqueous acrylics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
JPS6299322A (ja) 1985-10-24 1987-05-08 Shinjiro Tsuji 硬カプセル剤の新しい剤形
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
DE68920880D1 (de) * 1988-07-18 1995-03-09 Yamasa Shoyu Kk 1-amino-5-halogenouracile, verfahren zu deren herstellung und diese enthaltende cns-depressiva.
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
JP3122478B2 (ja) 1991-02-19 2001-01-09 帝國製薬株式会社 下部消化管放出型経口製剤
JPH0624962A (ja) 1992-07-09 1994-02-01 Green Cross Corp:The 腸溶徐放性製剤
WO1994004135A1 (en) 1992-08-13 1994-03-03 Teikoku Seiyaku Kabushiki Kaisha Oral preparation for release in lower digestive tracts
KR0157280B1 (ko) 1992-11-06 1998-11-16 나까토미 히로타카 하부소화관 방출성의 경구의약제제
JPH06256166A (ja) 1993-01-06 1994-09-13 ▲寛▼治 ▲高▼田 薬物放出制御製剤
JPH0710745A (ja) 1993-06-22 1995-01-13 Tanabe Seiyaku Co Ltd 放出開始時間制御型腸デリバリー経口製剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386801A2 (de) * 1985-09-26 1990-09-12 Chugai Seiyaku Kabushiki Kaisha Arzneimittel mit langsamer Wirkstofffreisetzung
EP0338383A2 (de) * 1988-04-16 1989-10-25 Schwarz Pharma Ag Oral zu verabreichende pharmazeutische Zubereitung mit kontrollierter Wirkstofffreisetzung und Verfahren zu deren Herstellung
EP0425699A1 (de) * 1989-05-11 1991-05-08 Chugai Seiyaku Kabushiki Kaisha Mundzubereitung zur verabreichung an bestimmter stelle des darmes
US5395628A (en) * 1989-12-28 1995-03-07 Tanabe Seiyaku Co., Ltd. Controlled release succinic acid microcapsules coated with aqueous acrylics

Also Published As

Publication number Publication date
CA2181502A1 (en) 1997-01-21
DE69624047T2 (de) 2003-08-14
KR970005279A (ko) 1997-02-19
ATE225165T1 (de) 2002-10-15
US6309666B1 (en) 2001-10-30
ID17428A (id) 1997-12-24
EP0754452B1 (de) 2002-10-02
CA2181502C (en) 2003-02-11
ES2184846T3 (es) 2003-04-16
EP0754452A3 (de) 1998-01-21
KR100389602B1 (ko) 2003-09-29
DE69624047D1 (de) 2002-11-07
CN1142944A (zh) 1997-02-19
DK0754452T3 (da) 2003-02-03
MX9602863A (es) 1997-09-30
TW514533B (en) 2002-12-21
CN1076964C (zh) 2002-01-02
EP0754452A2 (de) 1997-01-22
PT754452E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
SG80553A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
MX9500885A (es) Preparacion farmaceutica para administracion oral.
AU1488295A (en) Pharmaceutical composition
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
CA2344680A1 (en) Enteric and colonic delivery using hpmc capsules
CA2383220A1 (en) Controlled release pellet formulation
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
AU6770490A (en) Solid pharmaceutical compositions containing cimetidine
ATE251899T1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
MY125662A (en) Pharmaceutical formulations containing darifenacin
IE872110L (en) Oral therapeutic system having systemic action
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
CA2268175A1 (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA2065652A1 (en) Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
ATE290855T1 (de) Laminare arzneiform
ATE124255T1 (de) Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen.
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
HUT67167A (en) Water- and gastric juice-insoluble coating and oral preparations containing this coating
TH57760B (th) การลำเลียงยาสู่ลำไส้เล็กและลำไส้ใหญ่โดยใช้แคปซูลชนิด hpmc
CA2243863A1 (en) Gastrointestinal drug delivery system
BR9612800A (pt) Forma de dosagem farmacêutica para distribuição colÈnica.
MY114610A (en) Controlled drug delivery system for diltiazem.